相关实验视频
Updated: Sep 13, 2025

07:43
Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
20.4K
开发实验平台,以评估Helicobacter pylori HopQ与宿主CEACAM分子的相互作用
Nazanin Shans1, Maryam Esmaeili1, Kimia Abraheh1
1HPGC Research Group, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Iranian biomedical journal
|July 30, 2025
概括
研究人员开发了新的测定方法来研究Helicobacter pylori外膜蛋白Q (HopQ) 与宿主CEACAMs之间的相互作用. 这种相互作用对H. pylori感染至关重要,可以作为新药和疫苗的向.
科学领域:
- 微生物学 微生物学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 杆菌会导致胃肠道疾病,如和胃癌.
- 病原发生涉及CagA转位,最近的重点是HopQ-CEACAM相互作用.
- 这种相互作用是细菌殖民和信号传递的关键.
研究的目的:
- 开发新的平台来研究HopQ-CEACAM相互作用.
- 为了促进针对H. pylori的潜在治疗点的高通量查.
主要方法:
- 重组蛋白质的产生:HopQ,HopQ-GFP,HopQ-HRP,以及CEACAM1的N端域 (C1ND).
- 使用FACS分析对联体受体相互作用的评估.
- 使用了抗原和基于细胞的ELISA测试.
主要成果:
- 开发了使用复合融合蛋白 (HopQ-GFP,HopQ-HRP) 的抗原和基于细胞的平台.
- 证明了这些平台与重组C1ND.的有效相互作用.
- 已确认与胃细胞系上的CEACAM分子的相互作用 (MKN45,AGS).
结论:
- 开发的测试平台使HopQ-CEACAM相互作用的详细调查成为可能.
- 这些平台支持对抑制剂进行高通量选.
- 促进对H. pylori感染的潜在药物或疫苗候选人的识别.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
549
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
549
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
202
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
202

